Tofacitinib as a possible treatment for arthritis in an APDS2 patient.

Sun, Boyuan; Zhou, Shuang; Yang, Huaxia; Zhou, Jiaxin; Leng, Xiaomei; Zhang, Wen; Zeng, Xiaofeng

Sun, Boyuan; Zhou, Shuang; Yang, Huaxia; Zhou, Jiaxin; Leng, Xiaomei; Zhang, Wen; Zeng, Xiaofeng.

Afiliación

Sun B; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College.
Zhou S; Peking Union Medical College, M.D. Program.
Yang H; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College.
Zhou J; The Ministry of Education Key Laboratory, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China.
Leng X; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College.
Zhang W; The Ministry of Education Key Laboratory, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China.
Zeng X; Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College.

Rheumatology (Oxford) ; 62(3): e39-e41, 2023 03 01.

Article en En | MEDLINE | ID: mdl-35904543

Asunto(s)

Antirreumáticos; Artritis Reumatoide; Humanos; Artritis Reumatoide/tratamiento farmacológico; Piperidinas/uso terapéutico; Pirimidinas/uso terapéutico; Pirroles/uso terapéutico; Resultado del Tratamiento; Antirreumáticos/uso terapéutico; Inhibidores de Proteínas Quinasas/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google